Micheal Gruenberg, Ph.D. mgruen at
Sun Sep 17 10:15:33 EST 1995

We are a start-up biopharmaceutical company located in San Diego and
specializing in cell therapy. We have patents pending on a new technology
for ex-vivo differentiation of regulatory immune cells and their
subsequent expansion to clinically-relevent numbers (i.e. >50 billion),
without the use of IL-2. Our first product under development is a Th2
cell therapy for treatment of the chronic inflammation in rheumatoid

We are seeking experienced immunologists at the research scientist, 
post-doctoral and technician levels to initiate our pre-clinical testing.
Qualified candidates must have extensive experience in cell culture
and T-cell biology. Please e-mail your CV to me at the address below,
include a detailed description of your technical skills and salary
history. I will send all interested candidates a summary of our business
plan by return e-mail.

CellTherapy, Inc.
Micheal Gruenberg, Ph.D.
Director, Research and Development
e-mail: mgruen at


More information about the Immuno mailing list